Why the study?
The use of modest serial changes in the SOFA score as a surrogate efficacy marker in sepsis trials creates a need for increased clarity on how to assess the score consistently across different circumstances.
Design
Review
Authors
Loading...
Guidance for consistent SOFA scoring may strengthen outcome assessment in sepsis trials; leaves open validation in prospective multicentre studies.
Key points are not available for this paper at this time.
Lambden et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: